Literature DB >> 28652379

The mutant p53-ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1.

Magdalena Pruszko1,2, Elisa Milano3, Mattia Forcato4, Sara Donzelli3, Federica Ganci3, Silvia Di Agostino3, Simone De Panfilis5, Francesco Fazi6, David O Bates7, Silvio Bicciato4, Maciej Zylicz1, Alicja Zylicz1, Giovanni Blandino8, Giulia Fontemaggi8.   

Abstract

The abundant, nuclear-retained, metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) has been associated with a poorly differentiated and aggressive phenotype of mammary carcinomas. This long non-coding RNA (lncRNA) localizes to nuclear speckles, where it interacts with a subset of splicing factors and modulates their activity. In this study, we demonstrate that oncogenic splicing factor SRSF1 bridges MALAT1 to mutant p53 and ID4 proteins in breast cancer cells. Mutant p53 and ID4 delocalize MALAT1 from nuclear speckles and favor its association with chromatin. This enables aberrant recruitment of MALAT1 on VEGFA pre-mRNA and modulation of VEGFA isoforms expression. Interestingly, VEGFA-dependent expression signatures associate with ID4 expression specifically in basal-like breast cancers carrying TP53 mutations. Our results highlight a key role for MALAT1 in control of VEGFA isoforms expression in breast cancer cells expressing gain-of-function mutant p53 and ID4 proteins.
© 2017 The Authors.

Entities:  

Keywords:  ID4; MALAT1; SRSF1; VEGFA; mutant p53

Mesh:

Substances:

Year:  2017        PMID: 28652379      PMCID: PMC5538427          DOI: 10.15252/embr.201643370

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  68 in total

Review 1.  Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists.

Authors:  Sunil Badve; David J Dabbs; Stuart J Schnitt; Frederick L Baehner; Thomas Decker; Vincenzo Eusebi; Stephen B Fox; Shu Ichihara; Jocelyne Jacquemier; Sunil R Lakhani; José Palacios; Emad A Rakha; Andrea L Richardson; Fernando C Schmitt; Puay-Hoon Tan; Gary M Tse; Britta Weigelt; Ian O Ellis; Jorge S Reis-Filho
Journal:  Mod Pathol       Date:  2010-11-12       Impact factor: 7.842

2.  Sorting points into neighborhoods (SPIN): data analysis and visualization by ordering distance matrices.

Authors:  D Tsafrir; I Tsafrir; L Ein-Dor; O Zuk; D A Notterman; E Domany
Journal:  Bioinformatics       Date:  2005-02-18       Impact factor: 6.937

3.  RNA splicing control: yet another gene regulatory role for long nuclear noncoding RNAs.

Authors:  Xinying Zong; Vidisha Tripathi; Kannanganattu V Prasanth
Journal:  RNA Biol       Date:  2011-11-01       Impact factor: 4.652

4.  The mutant p53-ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1.

Authors:  Magdalena Pruszko; Elisa Milano; Mattia Forcato; Sara Donzelli; Federica Ganci; Silvia Di Agostino; Simone De Panfilis; Francesco Fazi; David O Bates; Silvio Bicciato; Maciej Zylicz; Alicja Zylicz; Giovanni Blandino; Giulia Fontemaggi
Journal:  EMBO Rep       Date:  2017-06-26       Impact factor: 8.807

5.  VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.

Authors:  David O Bates; Tai-Gen Cui; Joanne M Doughty; Matthias Winkler; Marto Sugiono; Jacqueline D Shields; Danielle Peat; David Gillatt; Steven J Harper
Journal:  Cancer Res       Date:  2002-07-15       Impact factor: 12.701

Review 6.  The role of VEGF 165b in pathophysiology.

Authors:  Maria Peiris-Pagès
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

7.  Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival.

Authors:  Aye A Thike; Puay H Tan; Murasaki Ikeda; Jabed Iqbal
Journal:  Histopathology       Date:  2015-11-02       Impact factor: 5.087

8.  Psip1/Ledgf p52 binds methylated histone H3K36 and splicing factors and contributes to the regulation of alternative splicing.

Authors:  Madapura M Pradeepa; Heidi G Sutherland; Jernej Ule; Graeme R Grimes; Wendy A Bickmore
Journal:  PLoS Genet       Date:  2012-05-17       Impact factor: 5.917

9.  A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains.

Authors:  John N Hutchinson; Alexander W Ensminger; Christine M Clemson; Christopher R Lynch; Jeanne B Lawrence; Andrew Chess
Journal:  BMC Genomics       Date:  2007-02-01       Impact factor: 3.969

10.  The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice.

Authors:  Es Rennel; E Waine; H Guan; Y Schüler; W Leenders; J Woolard; M Sugiono; D Gillatt; Es Kleinerman; Do Bates; Sj Harper
Journal:  Br J Cancer       Date:  2008-03-18       Impact factor: 7.640

View more
  44 in total

1.  Insight into the regulatory mechanism of VEGFA isoforms in p53 mutant breast cancer: can it be substantiated with solely in vitro studies?

Authors:  Jiadi Luo; Songqing Fan
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

2.  Zebrafish as experimental model to establish the contribution of mutant p53 and ID4 to breast cancer angiogenesis in vivo.

Authors:  Magdalena Pruszko; Elisa Milano; Alicja Zylicz; Maciej Zylicz; Giovanni Blandino; Giulia Fontemaggi
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

3.  Long non-coding RNA SLC16A1-AS1: its multiple tumorigenesis features and regulatory role in cell cycle in oral squamous cell carcinoma.

Authors:  Hao Feng; Xiaoqi Zhang; Wenli Lai; Jian Wang
Journal:  Cell Cycle       Date:  2020-05-25       Impact factor: 4.534

4.  The mutant p53-ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1.

Authors:  Magdalena Pruszko; Elisa Milano; Mattia Forcato; Sara Donzelli; Federica Ganci; Silvia Di Agostino; Simone De Panfilis; Francesco Fazi; David O Bates; Silvio Bicciato; Maciej Zylicz; Alicja Zylicz; Giovanni Blandino; Giulia Fontemaggi
Journal:  EMBO Rep       Date:  2017-06-26       Impact factor: 8.807

5.  Alternative splicing modulation mediated by G-quadruplex structures in MALAT1 lncRNA.

Authors:  Arpita Ghosh; Satya Prakash Pandey; Asgar Hussain Ansari; Jennifer Seematti Sundar; Praveen Singh; Yasmeen Khan; Mary Krishna Ekka; Debojyoti Chakraborty; Souvik Maiti
Journal:  Nucleic Acids Res       Date:  2022-01-11       Impact factor: 16.971

Review 6.  Mutant p53 on the Path to Metastasis.

Authors:  Qiaosi Tang; Zhenyi Su; Wei Gu; Anil K Rustgi
Journal:  Trends Cancer       Date:  2019-12-16

7.  Long noncoding RNA Malat1 regulates differential activation of macrophages and response to lung injury.

Authors:  Huachun Cui; Sami Banerjee; Sijia Guo; Na Xie; Jing Ge; Dingyuan Jiang; Martin Zörnig; Victor J Thannickal; Gang Liu
Journal:  JCI Insight       Date:  2019-02-21

8.  A lncRNA coordinates with Ezh2 to inhibit HIF-1α transcription and suppress cancer cell adaption to hypoxia.

Authors:  Xingwen Wang; Yudong Wang; Li Li; Xuting Xue; Hui Xie; Huaxing Shi; Ying Hu
Journal:  Oncogene       Date:  2019-11-29       Impact factor: 9.867

9.  Long Noncoding RNA PVT1 Promotes Stemness and Temozolomide Resistance through miR-365/ELF4/SOX2 Axis in Glioma.

Authors:  Rui Gong; Zhi-Qiang Li; Kai Fu; Chao Ma; Wei Wang; Jin-Cao Chen
Journal:  Exp Neurobiol       Date:  2021-06-30       Impact factor: 3.261

10.  LncRNA LINC00525 suppresses p21 expression via mRNA decay and triplex-mediated changes in chromatin structure in lung adenocarcinoma.

Authors:  Panqi Fang; Hao Chen; Zhifei Ma; Chencheng Han; Wenda Yin; Siwei Wang; Hongyu Zhu; Wenjia Xia; Jie Wang; Lin Xu; Tongyan Liu; Rong Yin
Journal:  Cancer Commun (Lond)       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.